Clinical Trials on Linfoma de Hodgkin
Total 5479 results
-
TakedaCompletedUntreated CD30-Positive Hodgkin's LymphomaJapan
-
Zentera Therapeutics HK LimitedTerminated
-
University Hospital, Clermont-FerrandCompletedLymphoma, Non-Hodgkin | Hodgkin Disease | Young AdultsFrance
-
Hoffmann-La RocheCompletedNon-Hodgkin LymphomaAlgeria, Morocco, Tunisia
-
Rhizen Pharmaceuticals SACompletedNon Hodgkin LymphomaUnited States, Australia
-
Abramson Cancer Center of the University of PennsylvaniaTerminatedNon-Hodgkin LymphomaUnited States
-
Soonchunhyang University HospitalCompletedNon-hodgkin LymphomaKorea, Republic of
-
BayerCompleted
-
Sidney Kimmel Cancer Center at Thomas Jefferson...TerminatedNon-Hodgkin LymphomaUnited States
-
University Hospital TuebingenCompleted
-
University Hospital TuebingenCompletedNon-Hodgkin LymphomaGermany
-
Gruppo Italiano Multiregionale per lo studio dei...University of Turin, Italy; Fondazione Italiana Linfomi ONLUS; Centro di Riferimento...CompletedLymphoma | Non-Hodgkin LymphomaItaly
-
The Lymphoma Academic Research OrganisationRoche Pharma AGTerminatedRefractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin LymphomaFrance
-
Genzyme, a Sanofi CompanyCompletedLymphoma | Multiple Myeloma | Non Hodgkin's Lymphoma | Hodgkin's DiseaseGermany
-
Case Comprehensive Cancer CenterActive, not recruitingNon-hodgkin LymphomaUnited States
-
Benjamin TomlinsonActive, not recruitingNon-Hodgkin LymphomaUnited States
-
New York Medical CollegeCompletedNon Hodgkin Lymphoma
-
AstraZenecaTerminatedNon-Hodgkin LymphomaSpain, United States, Korea, Republic of, France, Portugal, Australia, Italy
-
Teva Branded Pharmaceutical Products R&D, Inc.Completed
-
Tahir LatifActive, not recruitingNon Hodgkin LymphomaUnited States
-
Spectrum Pharmaceuticals, IncThe Leukemia and Lymphoma SocietyTerminated
-
ImmunityBio, Inc.Withdrawn
-
Timmune Biotech Inc.Unknown
-
Alberta Health Services, CalgaryUnknownNon-Hodgkin LymphomaCanada
-
Multinational Center for Quality of Life Research...UnknownRelapsed or Refractory Hodgkin's LymphomaRussian Federation
-
Gustave Roussy, Cancer Campus, Grand ParisSociété Française des Cancers et Leucémies de l'Enfant et de l'Adolescent...Completed
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)Completed
-
Kjeld SchmiegelowOdense University Hospital; Aarhus University Hospital Skejby; Aalborg University...WithdrawnNon-Hodgkin LymphomaDenmark
-
Seagen Inc.Genentech, Inc.Completed
-
National University Hospital, SingaporeCompleted
-
Centre de recherche du Centre hospitalier universitaire...Unknown
-
NovartisCompleted
-
Stanford UniversityNational Institute of Allergy and Infectious Diseases (NIAID); National Institutes...CompletedLymphoma | Hodgkin's Lymphoma | Hodgkin DiseaseUnited States
-
PETHEMA FoundationRecruitingLeukemia, Myeloid, Acute | De Novo | Age More 60yrSpain
-
Aibin Liang，MD，Ph.D.RecruitingRefractory or Relapsed B-cell Non-Hodgkin LymphomaChina
-
National Cancer Institute (NCI)Active, not recruitingAnn Arbor Stage III Non-Hodgkin Lymphoma | Ann Arbor Stage IV Non-Hodgkin Lymphoma | Solid NeoplasmUnited States
-
Merck Sharp & Dohme LLCActive, not recruitingHodgkin's Lymphoma | Primary Mediastinal Large B-cell Lymphoma (PMBCL)Canada, United States, Brazil, Czechia, France, Italy, Poland, Russian Federation, South Africa, Turkey, Ukraine
-
Fondazione Italiana Linfomi ONLUSCompletedDiffuse Large B-cells Non-Hodgkin LymphomaItaly
-
Janssen Research & Development, LLCPharmacyclics LLC.CompletedCD20-positive B-cell Non-Hodgkin LymphomaUnited States, France
-
Memorial Sloan Kettering Cancer CenterWeill Medical College of Cornell University; Queen's University, Kingston,...CompletedLeukemia | Hodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Myelodysplastic SyndromeUnited States
-
Guangzhou Excelmab Inc.RecruitingSafety and Efficacy of EX103 in Subjects With Relapsed/Refractory CD20-Positive Non-Hodgkin LymphomaCD20-positive Non-Hodgkin LymphomaChina
-
Conjupro Biotherapeutics, Inc.SuspendedCD20 Positive Non Hodgkin LymphomaUnited States
-
Adagene (Suzhou) LimitedTerminatedSolid Tumor | Non Hodgkin LymphomaChina
-
The Christie NHS Foundation TrustTerminatedCD19 Positive Non-Hodgkin LymphomaUnited Kingdom
-
Seoul National University HospitalGyeongsang National University Hospital; Hallym University Medical Center; Kyunghee...TerminatedCD20-positive Non-Hodgkin LymphomaKorea, Republic of
-
Washington University School of MedicineTerminatedLymphoma, Non-Hodgkin | Hodgkin DiseaseUnited States
-
University of WashingtonJanssen PharmaceuticalsActive, not recruitingRecurrent Transformed B-Cell Non-Hodgkin Lymphoma | Refractory Transformed B-Cell Non-Hodgkin LymphomaUnited States
-
SecuraBioCompletedIndolent Non-Hodgkin LymphomaKorea, Republic of, Czechia, United States, United Kingdom, Italy, Poland, Russian Federation, Germany
-
American Scitech InternationalBristol-Myers Squibb; Eli Lilly and CompanyUnknownHodgkin's LymphomaUnited States
-
University of MiamiTerminatedEpstein Barr Virus Associated Non Hodgkin's Lymphoma | Epstein Barr Virus Associated Hodgkin's Lymphoma | Post-Transplant Lymphoproliferative DiseaseUnited States